2-chloro-5-[5-[(1S)-1-[[2-[(2S,4R)-9-(difluoromethyl)-5,5-difluoro-7,8-diazatricyclo[4.3.0.02,4]nona-1(6),8-dien-7-yl]acetyl]amino]-2-(3,5-difluorophenyl)ethyl]-1H-pyrazolo[4,5-b]pyridin-6-yl]-N-(1-methylcyclopropyl)sulfonylbenzamide
C35H28ClF6N7O4S — CID 154629061
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-chloro-5-[5-[(1S)-1-[[2-[(2S,4R)-9-(difluoromethyl)-5,5-difluoro-7,8-diazatricyclo[4.3.0.02,4]nona-1(6),8-dien-7-yl]acetyl]amino]-2-(3,5-difluorophenyl)ethyl]-1H-pyrazolo[4,5-b]pyridin-6-yl]-N-(1-methylcyclopropyl)sulfonylbenzamide
2-chloro-5-[5-[(1S)-1-[[2-[(2S,4R)-9-(difluoromethyl)-5,5-difluoro-7,8-diazatricyclo[4.3.0.02,4]nona-1(6),8-dien-7-yl]acetyl]amino]-2-(3,5-difluorophenyl)ethyl]-1H-pyrazolo[4,5-b]pyridin-6-yl]-N-(1-methylcyclopropyl)sulfonylbenzamide (PubChem CID 154629061) has the molecular formula C35H28ClF6N7O4S and a molecular weight of 792.16 g/mol. Its IUPAC name is 2-chloro-5-[5-[(1S)-1-[[2-[(2S,4R)-9-(difluoromethyl)-5,5-difluoro-7,8-diazatricyclo[4.3.0.02,4]nona-1(6),8-dien-7-yl]acetyl]amino]-2-(3,5-difluorophenyl)ethyl]-1H-pyrazolo[4,5-b]pyridin-6-yl]-N-(1-methylcyclopropyl)sulfonylbenzamide.
Molecular Properties
| Compound Name | 2-chloro-5-[5-[(1S)-1-[[2-[(2S,4R)-9-(difluoromethyl)-5,5-difluoro-7,8-diazatricyclo[4.3.0.02,4]nona-1(6),8-dien-7-yl]acetyl]amino]-2-(3,5-difluorophenyl)ethyl]-1H-pyrazolo[4,5-b]pyridin-6-yl]-N-(1-methylcyclopropyl)sulfonylbenzamide |
|---|---|
| PubChem CID | 154629061 |
| Molecular Formula | C35H28ClF6N7O4S |
| Molecular Weight | 792.16 g/mol |
| Exact Mass | 791.15 |
| IUPAC Name | 2-chloro-5-[5-[(1S)-1-[[2-[(2S,4R)-9-(difluoromethyl)-5,5-difluoro-7,8-diazatricyclo[4.3.0.02,4]nona-1(6),8-dien-7-yl]acetyl]amino]-2-(3,5-difluorophenyl)ethyl]-1H-pyrazolo[4,5-b]pyridin-6-yl]-N-(1-methylcyclopropyl)sulfonylbenzamide |
| SMILES | CC1(S(=O)(=O)NC(=O)c2cc(-c3cc4[nH]ncc4nc3[C@H](Cc3cc(F)cc(F)c3)NC(=O)Cn3nc(C(F)F)c4c3C(F)(F)[C@@H]3C[C@H]43)ccc2Cl)CC1 |
| InChI | InChI=1S/C35H28ClF6N7O4S/c1-34(4-5-34)54(52,53)48-33(51)21-9-16(2-3-23(21)36)19-12-24-26(13-43-46-24)45-29(19)25(8-15-6-17(37)10-18(38)7-15)44-27(50)14-49-31-28(30(47-49)32(39)40)20-11-22(20)35(31,41)42/h2-3,6-7,9-10,12-13,20,22,25,32H,4-5,8,11,14H2,1H3,(H,43,46)(H,44,50)(H,48,51)/t20-,22+,25-/m0/s1 |
| InChIKey | KVLZALGADUQVAL-HOKHCIIBSA-N |
| XLogP | 6.61 |
| TPSA | 151.73 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 11 |
| Heavy Atoms | 54 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 792.16 |
| LogP ≤ 5 | 6.61 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 154629061 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.